Samuel Joseph Shubrooks, Jr., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Angioplasty, Balloon, Coronary | 25 | 2011 | 1725 | 1.030 |
Why?
|
| Coronary Disease | 18 | 2011 | 5914 | 0.420 |
Why?
|
| Atherectomy, Coronary | 4 | 2000 | 137 | 0.290 |
Why?
|
| Angina Pectoris | 7 | 2000 | 959 | 0.260 |
Why?
|
| Stents | 8 | 2003 | 3179 | 0.210 |
Why?
|
| Coronary Artery Bypass | 9 | 2003 | 2188 | 0.200 |
Why?
|
| Acceleration | 9 | 1975 | 189 | 0.190 |
Why?
|
| Hospital Mortality | 8 | 2011 | 5294 | 0.180 |
Why?
|
| Aerospace Medicine | 9 | 1975 | 95 | 0.150 |
Why?
|
| Mitral Valve Stenosis | 3 | 1993 | 341 | 0.150 |
Why?
|
| Bioterrorism | 2 | 2007 | 144 | 0.130 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1999 | 537 | 0.130 |
Why?
|
| Angioscopy | 3 | 2003 | 47 | 0.130 |
Why?
|
| Communicable Diseases, Emerging | 2 | 2007 | 148 | 0.120 |
Why?
|
| Angina Pectoris, Variant | 3 | 1979 | 53 | 0.120 |
Why?
|
| New England | 9 | 2003 | 1054 | 0.110 |
Why?
|
| Coronary Thrombosis | 3 | 2003 | 440 | 0.100 |
Why?
|
| Gravitation | 6 | 1975 | 82 | 0.100 |
Why?
|
| Catheterization | 2 | 1993 | 1428 | 0.090 |
Why?
|
| Echocardiography | 4 | 1996 | 4989 | 0.080 |
Why?
|
| Coronary Vessels | 4 | 2007 | 3096 | 0.080 |
Why?
|
| Myocardial Infarction | 8 | 2011 | 11460 | 0.070 |
Why?
|
| Coronary Angiography | 8 | 2007 | 4471 | 0.060 |
Why?
|
| Cardiology | 1 | 1996 | 1656 | 0.060 |
Why?
|
| Registries | 4 | 2011 | 8224 | 0.060 |
Why?
|
| Public Health | 2 | 2007 | 2669 | 0.060 |
Why?
|
| Ergonovine | 2 | 1979 | 14 | 0.050 |
Why?
|
| Shock, Cardiogenic | 3 | 2011 | 709 | 0.050 |
Why?
|
| Myocardial Contraction | 2 | 1979 | 1515 | 0.050 |
Why?
|
| Complementary Therapies | 1 | 2005 | 486 | 0.050 |
Why?
|
| Massachusetts | 3 | 2011 | 8830 | 0.050 |
Why?
|
| Heart Diseases | 2 | 1993 | 2781 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2001 | 563 | 0.040 |
Why?
|
| Pericarditis, Constrictive | 1 | 1979 | 46 | 0.040 |
Why?
|
| Protective Clothing | 3 | 1974 | 103 | 0.040 |
Why?
|
| Survival Analysis | 5 | 2011 | 10090 | 0.040 |
Why?
|
| Hemodynamics | 5 | 1996 | 4159 | 0.040 |
Why?
|
| Middle Aged | 28 | 2011 | 220895 | 0.040 |
Why?
|
| Thrombosis | 1 | 1993 | 2942 | 0.040 |
Why?
|
| Mitral Valve | 2 | 1977 | 1465 | 0.040 |
Why?
|
| Heart Septum | 1 | 1979 | 301 | 0.040 |
Why?
|
| Hypertension, Pulmonary | 1 | 2009 | 1578 | 0.040 |
Why?
|
| Male | 38 | 2011 | 360804 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2001 | 3416 | 0.040 |
Why?
|
| Retreatment | 1 | 1999 | 598 | 0.040 |
Why?
|
| Sex Factors | 6 | 2011 | 10552 | 0.040 |
Why?
|
| Rheumatic Fever | 1 | 1977 | 73 | 0.040 |
Why?
|
| Coronary Stenosis | 1 | 2003 | 794 | 0.040 |
Why?
|
| Sinoatrial Node | 1 | 1977 | 99 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 4 | 1982 | 2244 | 0.030 |
Why?
|
| Aged | 23 | 2011 | 169289 | 0.030 |
Why?
|
| Atrioventricular Node | 1 | 1977 | 180 | 0.030 |
Why?
|
| Cardiovascular Diseases | 3 | 2007 | 15500 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2001 | 2281 | 0.030 |
Why?
|
| Humans | 56 | 2011 | 761504 | 0.030 |
Why?
|
| Treatment Outcome | 12 | 2003 | 64680 | 0.030 |
Why?
|
| Logistic Models | 5 | 2002 | 13255 | 0.030 |
Why?
|
| Aged, 80 and over | 10 | 2011 | 58976 | 0.030 |
Why?
|
| Probability | 1 | 2001 | 2477 | 0.030 |
Why?
|
| 1-Propanol | 1 | 1975 | 15 | 0.030 |
Why?
|
| Age Distribution | 1 | 2001 | 2880 | 0.030 |
Why?
|
| Safety | 1 | 2000 | 1150 | 0.030 |
Why?
|
| Myocardial Ischemia | 2 | 1996 | 2113 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2001 | 2645 | 0.030 |
Why?
|
| Female | 30 | 2011 | 392644 | 0.030 |
Why?
|
| Vascular Diseases | 1 | 2003 | 1161 | 0.030 |
Why?
|
| Coronary Vessel Anomalies | 1 | 1978 | 307 | 0.030 |
Why?
|
| Multivariate Analysis | 4 | 2001 | 12059 | 0.030 |
Why?
|
| Recurrence | 4 | 2000 | 8465 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 1999 | 1204 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2001 | 1315 | 0.030 |
Why?
|
| Vascular Resistance | 2 | 1975 | 930 | 0.030 |
Why?
|
| Calcium | 1 | 2007 | 5722 | 0.030 |
Why?
|
| Angina, Unstable | 1 | 1998 | 888 | 0.030 |
Why?
|
| Cost Control | 1 | 1996 | 628 | 0.030 |
Why?
|
| Heart Valve Diseases | 2 | 1977 | 1027 | 0.030 |
Why?
|
| Coronary Artery Disease | 2 | 2007 | 6403 | 0.030 |
Why?
|
| Valsalva Maneuver | 1 | 1973 | 99 | 0.030 |
Why?
|
| Pressure | 2 | 1975 | 1154 | 0.030 |
Why?
|
| Coronary Circulation | 2 | 1996 | 1569 | 0.030 |
Why?
|
| Carotid Sinus | 1 | 1972 | 44 | 0.030 |
Why?
|
| Risk Factors | 9 | 2003 | 74206 | 0.020 |
Why?
|
| Pressoreceptors | 1 | 1972 | 99 | 0.020 |
Why?
|
| Follow-Up Studies | 7 | 2011 | 39106 | 0.020 |
Why?
|
| Heart Conduction System | 1 | 1977 | 1007 | 0.020 |
Why?
|
| Electrocardiography | 5 | 1995 | 6377 | 0.020 |
Why?
|
| Shock, Hemorrhagic | 1 | 1973 | 223 | 0.020 |
Why?
|
| Sodium | 3 | 1974 | 1588 | 0.020 |
Why?
|
| Acidosis | 1 | 1973 | 268 | 0.020 |
Why?
|
| Pulmonary Circulation | 1 | 1973 | 737 | 0.020 |
Why?
|
| Thinking | 2 | 1963 | 320 | 0.020 |
Why?
|
| Risk Assessment | 4 | 2011 | 23995 | 0.020 |
Why?
|
| Prospective Studies | 8 | 2003 | 54425 | 0.020 |
Why?
|
| Bacteremia | 1 | 1997 | 979 | 0.020 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1979 | 1310 | 0.020 |
Why?
|
| Survival Rate | 2 | 2001 | 12725 | 0.020 |
Why?
|
| Heart Rate | 5 | 1973 | 4195 | 0.020 |
Why?
|
| Heart Ventricles | 3 | 1978 | 3807 | 0.020 |
Why?
|
| Positive-Pressure Respiration | 1 | 1973 | 639 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 1992 | 1096 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 2 | 1996 | 1496 | 0.020 |
Why?
|
| Cause of Death | 1 | 1999 | 3683 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 2000 | 2471 | 0.020 |
Why?
|
| Prolapse | 2 | 1977 | 63 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 1999 | 8529 | 0.020 |
Why?
|
| Echocardiography, Transesophageal | 1 | 1993 | 1086 | 0.020 |
Why?
|
| Fellowships and Scholarships | 1 | 1996 | 1117 | 0.020 |
Why?
|
| Age Factors | 4 | 2011 | 18395 | 0.020 |
Why?
|
| Time Factors | 5 | 2001 | 39967 | 0.020 |
Why?
|
| Schizophrenic Psychology | 2 | 1963 | 1647 | 0.020 |
Why?
|
| Qi | 1 | 2005 | 15 | 0.020 |
Why?
|
| Adult | 19 | 2011 | 221177 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 1994 | 1797 | 0.010 |
Why?
|
| Incidence | 2 | 2000 | 21353 | 0.010 |
Why?
|
| Dogs | 3 | 1975 | 3839 | 0.010 |
Why?
|
| Fluphenazine | 1 | 1963 | 35 | 0.010 |
Why?
|
| Thioridazine | 1 | 1963 | 33 | 0.010 |
Why?
|
| Phenothiazines | 1 | 1963 | 61 | 0.010 |
Why?
|
| Clinical Competence | 1 | 1999 | 4792 | 0.010 |
Why?
|
| Chlorpromazine | 1 | 1963 | 111 | 0.010 |
Why?
|
| ROC Curve | 2 | 2003 | 3579 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2001 | 15842 | 0.010 |
Why?
|
| Aortic Valve Stenosis | 1 | 1996 | 2001 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2007 | 20570 | 0.010 |
Why?
|
| Analysis of Variance | 2 | 2003 | 6228 | 0.010 |
Why?
|
| Concept Formation | 1 | 1963 | 161 | 0.010 |
Why?
|
| Syncope | 2 | 1977 | 427 | 0.010 |
Why?
|
| Kidney | 2 | 1974 | 7048 | 0.010 |
Why?
|
| Psychological Tests | 1 | 1963 | 640 | 0.010 |
Why?
|
| Phenytoin | 1 | 1982 | 190 | 0.010 |
Why?
|
| Blood Pressure | 6 | 1974 | 8481 | 0.010 |
Why?
|
| Digoxin | 1 | 1982 | 246 | 0.010 |
Why?
|
| Data Collection | 2 | 1999 | 3322 | 0.010 |
Why?
|
| Radiography | 1 | 2011 | 6965 | 0.010 |
Why?
|
| Autonomic Agents | 1 | 1979 | 7 | 0.010 |
Why?
|
| Chest Pain | 1 | 2007 | 1091 | 0.010 |
Why?
|
| Placebos | 1 | 1963 | 1667 | 0.010 |
Why?
|
| Feasibility Studies | 2 | 2003 | 5247 | 0.010 |
Why?
|
| Spasm | 1 | 1979 | 130 | 0.010 |
Why?
|
| Regression Analysis | 2 | 1998 | 6343 | 0.010 |
Why?
|
| Oxygen Consumption | 2 | 1975 | 1866 | 0.010 |
Why?
|
| Heart Block | 2 | 1977 | 386 | 0.010 |
Why?
|
| Odds Ratio | 2 | 2003 | 9646 | 0.010 |
Why?
|
| Heart Murmurs | 1 | 1978 | 92 | 0.010 |
Why?
|
| Mitral Valve Insufficiency | 2 | 1977 | 1400 | 0.010 |
Why?
|
| Disease-Free Survival | 2 | 2000 | 6814 | 0.010 |
Why?
|
| Arrhythmia, Sinus | 1 | 1977 | 48 | 0.010 |
Why?
|
| Natriuresis | 2 | 1974 | 105 | 0.010 |
Why?
|
| Myxoma | 1 | 1977 | 114 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 1979 | 592 | 0.010 |
Why?
|
| Diagnosis-Related Groups | 1 | 1998 | 449 | 0.010 |
Why?
|
| Fistula | 1 | 1978 | 212 | 0.010 |
Why?
|
| Physical Exertion | 3 | 1973 | 667 | 0.010 |
Why?
|
| Cineangiography | 1 | 1975 | 108 | 0.010 |
Why?
|
| Angiocardiography | 1 | 1975 | 149 | 0.010 |
Why?
|
| Prognosis | 4 | 1999 | 29625 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2011 | 3801 | 0.010 |
Why?
|
| Bradycardia | 1 | 1977 | 299 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2003 | 14666 | 0.010 |
Why?
|
| Consensus | 1 | 2005 | 3123 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2011 | 7967 | 0.010 |
Why?
|
| Environment, Controlled | 1 | 1975 | 42 | 0.010 |
Why?
|
| Streptococcus agalactiae | 1 | 1997 | 337 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1975 | 328 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 1975 | 384 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 15266 | 0.010 |
Why?
|
| Central Venous Pressure | 1 | 1974 | 79 | 0.010 |
Why?
|
| Heart Neoplasms | 1 | 1977 | 362 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2005 | 2882 | 0.010 |
Why?
|
| Autonomic Nervous System | 1 | 1979 | 703 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 1978 | 973 | 0.010 |
Why?
|
| Propranolol | 1 | 1975 | 489 | 0.010 |
Why?
|
| Bundle-Branch Block | 1 | 1975 | 276 | 0.010 |
Why?
|
| Medical Records | 1 | 1999 | 1408 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2005 | 3905 | 0.010 |
Why?
|
| Plasma Volume | 1 | 1972 | 31 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1975 | 1379 | 0.010 |
Why?
|
| Potassium | 2 | 1974 | 1311 | 0.010 |
Why?
|
| Tachycardia | 1 | 1975 | 600 | 0.010 |
Why?
|
| Emergencies | 1 | 1999 | 1217 | 0.010 |
Why?
|
| Blood Volume | 1 | 1974 | 547 | 0.010 |
Why?
|
| Streptococcal Infections | 1 | 1997 | 617 | 0.010 |
Why?
|
| Oxygen | 2 | 1975 | 4227 | 0.010 |
Why?
|
| Bicarbonates | 1 | 1973 | 292 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2005 | 3415 | 0.010 |
Why?
|
| Deficiency Diseases | 1 | 1972 | 74 | 0.010 |
Why?
|
| Protective Devices | 1 | 1972 | 72 | 0.010 |
Why?
|
| Pulmonary Heart Disease | 1 | 1971 | 34 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1994 | 15631 | 0.010 |
Why?
|
| Echocardiography, Doppler | 1 | 1996 | 897 | 0.010 |
Why?
|
| Renin | 1 | 1974 | 641 | 0.010 |
Why?
|
| Heart Atria | 1 | 1978 | 1345 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2009 | 7390 | 0.010 |
Why?
|
| Morbidity | 1 | 1997 | 1750 | 0.010 |
Why?
|
| Creatinine | 2 | 1974 | 1899 | 0.010 |
Why?
|
| Mortality | 1 | 2002 | 2901 | 0.010 |
Why?
|
| Hematocrit | 1 | 1972 | 623 | 0.010 |
Why?
|
| Pacemaker, Artificial | 2 | 1975 | 807 | 0.010 |
Why?
|
| Rest | 1 | 1975 | 918 | 0.010 |
Why?
|
| Perfusion | 1 | 1975 | 1373 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 1963 | 3067 | 0.010 |
Why?
|
| Retrospective Studies | 4 | 2003 | 80636 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1973 | 1496 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1971 | 563 | 0.010 |
Why?
|
| Respiration | 2 | 1973 | 1657 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1973 | 1147 | 0.000 |
Why?
|
| Cerebrospinal Fluid | 1 | 1972 | 544 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1973 | 2496 | 0.000 |
Why?
|
| Feedback | 1 | 1972 | 791 | 0.000 |
Why?
|
| Staphylococcal Infections | 1 | 1997 | 1408 | 0.000 |
Why?
|
| United States | 1 | 1996 | 72334 | 0.000 |
Why?
|
| Stress, Physiological | 1 | 1975 | 1403 | 0.000 |
Why?
|
| Stroke Volume | 1 | 2001 | 5496 | 0.000 |
Why?
|
| Muscle Contraction | 1 | 1972 | 1201 | 0.000 |
Why?
|
| Diet | 3 | 1974 | 8075 | 0.000 |
Why?
|
| Ischemic Attack, Transient | 1 | 1972 | 882 | 0.000 |
Why?
|
| Water | 1 | 1972 | 1411 | 0.000 |
Why?
|
| Homeostasis | 2 | 1974 | 3323 | 0.000 |
Why?
|
| Aortic Valve | 1 | 1996 | 1955 | 0.000 |
Why?
|
| Aorta, Thoracic | 1 | 1972 | 1096 | 0.000 |
Why?
|
| Body Mass Index | 1 | 2003 | 12953 | 0.000 |
Why?
|
| Risk | 1 | 1997 | 9610 | 0.000 |
Why?
|
| Vision Disorders | 1 | 1972 | 1088 | 0.000 |
Why?
|
| Schizophrenia | 1 | 1963 | 6937 | 0.000 |
Why?
|
| Quality of Health Care | 1 | 1999 | 4330 | 0.000 |
Why?
|
| Adolescent | 4 | 1978 | 88319 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1975 | 10766 | 0.000 |
Why?
|
| Cardiac Surgical Procedures | 1 | 1998 | 3627 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1998 | 12974 | 0.000 |
Why?
|
| Myocardium | 1 | 1975 | 4726 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 1995 | 12463 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 1998 | 20098 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 1997 | 22176 | 0.000 |
Why?
|
| Animals | 4 | 1975 | 168459 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2001 | 41487 | 0.000 |
Why?
|
| Diuresis | 1 | 1974 | 106 | 0.000 |
Why?
|
| Death, Sudden | 1 | 1975 | 301 | 0.000 |
Why?
|
| Lung | 1 | 1971 | 10000 | 0.000 |
Why?
|
| Heart Failure | 1 | 1997 | 11669 | 0.000 |
Why?
|
| Indicator Dilution Techniques | 1 | 1971 | 43 | 0.000 |
Why?
|
| Mathematics | 1 | 1971 | 707 | 0.000 |
Why?
|
| Shock | 1 | 1971 | 314 | 0.000 |
Why?
|
| Cardiac Output | 1 | 1971 | 831 | 0.000 |
Why?
|
| Autopsy | 1 | 1971 | 1008 | 0.000 |
Why?
|
| Organ Size | 1 | 1971 | 2254 | 0.000 |
Why?
|
| Hand | 1 | 1972 | 902 | 0.000 |
Why?
|